Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Centene Corp

Healthcare US CNC

59.55USD
-0.44(0.73%)

Last update at 2026-06-03T20:08:00Z

Day Range

58.2360.50
LowHigh

52 Week Range

25.0864.15
LowHigh

Fundamentals

  • Previous Close 59.99
  • Market Cap19247.97M
  • Volume3834022
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA2561.00M
  • Revenue TTM176151.00M
  • Revenue Per Share TTM357.22
  • Gross Profit TTM 18449.00M
  • Diluted EPS TTM-13.53

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6727.96300M 4257.00M 3598.00M 1962.00M 1813.00M
Minority interest 3.00M 11.00M 3.00M 3.00M 11.00M
Net income -6673.00000M 3305.00M 2702.00M 1202.00M 1347.00M
Selling general administrative 13263.38M 12400.00M 12273.00M 20919.00M 10166.00M
Selling and marketing expenses - - - - -
Gross profit 23833.44M 16829.00M 31541.00M 16656.00M 14199.00M
Reconciled depreciation 1275.00M 1241.00M 1452.00M 1553.00M 1476.00M
Ebit -6415.37500M 4959.00M 2930.00M 2627.00M 2478.00M
Ebitda -5140.37500M 6200.00M 2930.00M 4058.00M 3954.00M
Depreciation and amortization 1275.00M 1241.00M 1293.00M 1431.00M 1476.00M
Non operating income net other - - - 1279.00M 819.00M
Operating income -7618.37500M 3175.00M 2930.00M 3636.00M 3263.00M
Other operating expenses 202395.38M 159896.00M 151069.00M 140911.00M 122719.00M
Interest expense 678.00M 702.00M 725.00M 665.00M 665.00M
Tax provision -51.00000M 963.00M 1174.00M 760.00M 477.00M
Interest income 678.00M 702.00M - 665.00M 665.00M
Net interest income -678.00000M -702.00000M -716.00000M -665.00000M -665.00000M
Extraordinary items 4.00M - - - -
Non recurring - - - 2318.00M 1479.00M
Other items - - - - -
Income tax expense -50.96300M 963.00M 899.00M 760.00M 477.00M
Total revenue 194777.00M 163071.00M 153999.00M 144547.00M 125982.00M
Total operating expenses 31451.81M 13654.00M 28611.00M 13020.00M 10936.00M
Cost of revenue 170943.56M 146242.00M 122458.00M 127891.00M 111783.00M
Total other income expense net 890.41M 1082.00M 668.00M 644.00M 29.00M
Discontinued operations - - - - -
Net income from continuing ops -6677.00000M 3294.00M 2441.00M 1202.00M 1336.00M
Net income applicable to common shares -6674.00000M 3305.00M - 1202.00M 1347.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 77661.00M 82445.00M 84641.00M 76870.00M 78375.00M
Intangible assets 4530.00M 5409.00M 6101.00M 6911.00M 7824.00M
Earning assets - - - - -
Other current assets 20050.00M 1601.00M 21104.00M 2461.00M 1602.00M
Total liab 57605.00M 55935.00M 58685.00M 52633.00M 51353.00M
Total stockholder equity 19953.00M 26410.00M 25840.00M 24057.00M 26795.00M
Deferred long term liab - - - - -
Other current liab -50.00000M 20316.00M 19294.00M 18379.00M 16571.00M
Common stock 1.00M 1.00M 1.00M 1.00M 1.00M
Capital stock 1.00M 1.00M 1.00M 1.00M 1.00M
Retained earnings 8674.00M 15348.00M 12043.00M 9341.00M 8139.00M
Other liab - - - 3098.00M 7017.00M
Good will 10835.00M 17558.00M 17558.00M 18812.00M 19771.00M
Other assets 1940.00M 1624.00M - 1217.00M 4849.00M
Cash 17888.00M 14063.00M 17193.00M 12074.00M 13118.00M
Cash and equivalents 17888.00M 14063.00M - 12074.00M 13118.00M
Total current liabilities 21476.00M 34261.00M 36716.00M 28464.00M 25765.00M
Current deferred revenue 736.00M 661.00M 715.00M 478.00M 434.00M
Net debt 889.00M 5366.00M 1684.00M 5946.00M 5720.00M
Short term debt 196.00M 268.00M 287.00M 82.00M 267.00M
Short long term debt 50.00M 110.00M 119.00M 82.00M 267.00M
Short long term debt total 18777.00M 19429.00M 18877.00M 18020.00M 18838.00M
Other stockholder equity 11336.00M 11565.00M 14448.00M 15847.00M 18578.00M
Property plant equipment 2037.00M 2426.00M - 2432.00M 3391.00M
Total current assets 35993.00M 37999.00M 40756.00M 30128.00M 28497.00M
Long term investments 17035.00M 17429.00M 16286.00M 14684.00M 14043.00M
Net tangible assets - - - -1610.00000M -800.00000M
Short term investments 2432.00M 2622.00M 2459.00M 2321.00M 1539.00M
Net receivables 18105.00M 19713.00M 15532.00M 13272.00M 12238.00M
Long term debt 17351.00M 18423.00M 17710.00M 17938.00M 18571.00M
Inventory - - -35184.00000M - -
Accounts payable 20544.00M 13016.00M 16252.00M 9525.00M 8493.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 124.00M 145.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -58.00000M -504.00000M -652.00000M -1132.00000M 77.00M
Additional paid in capital - - - - -
Common stock total equity - - - 1.00M 1.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 9341.00M 8139.00M
Treasury stock - - - -4213.00000M -1094.00000M
Accumulated amortization - - - - -
Non currrent assets other 2156.00M 1624.00M 1525.00M 3903.00M 4849.00M
Deferred long term asset charges - - - - -
Non current assets total 41668.00M 44446.00M 43885.00M 46742.00M 49878.00M
Capital lease obligations 761.00M 896.00M 1048.00M 3313.00M -
Long term debt total 17351.00M 18423.00M - 17938.00M 18571.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 1239.00M -1052.00000M -21.00000M -2921.00000M -3299.00000M
Change to liabilities - - - 3660.00M 1032.00M
Total cashflows from investing activities 453.00M -1052.00000M - -2921.00000M -3299.00000M
Net borrowings -1145.00000M 678.00M - -1144.00000M 1833.00M
Total cash from financing activities -1602.00000M -2406.00000M -1658.00000M -4197.00000M 1362.00M
Change to operating activities - - - 3369.00M 2797.00M
Net income -6677.00000M 3294.00M 2702.00M 1202.00M 1336.00M
Change in cash 3825.00M -3130.00000M 5122.00M -884.00000M 2257.00M
Begin period cash flow 14156.00M 17193.00M 12330.00M 13214.00M 10957.00M
End period cash flow 17957.00M 14063.00M 17452.00M 12330.00M 13214.00M
Total cash from operating activities 5088.00M 154.00M 8053.00M 6261.00M 4205.00M
Issuance of capital stock 37.00M 46.00M 40.00M 70.00M 35.00M
Depreciation 1275.00M 1241.00M 1293.00M 1553.00M 1476.00M
Other cashflows from investing activities 1239.00M 990.00M - -1917.00000M 19.00M
Dividends paid - - 88.00M - 35.00M
Change to inventory - - 2122.00M - -1141.00000M
Change to account receivables 1480.00M -4333.00000M -2380.00000M -1627.00000M -2453.00000M
Sale purchase of stock -475.00000M -3124.00000M -1633.00000M -3096.00000M -297.00000M
Other cashflows from financing activities -19.00000M -6.00000M -88.00000M -41.00000M -174.00000M
Change to netincome - - - 1314.00M 6.00M
Capital expenditures 767.00M 644.00M 799.00M 1004.00M 910.00M
Change receivables - - - -1627.00000M -2453.00000M
Cash flows other operating - - - 159.00M -208.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -857.00000M 2268.00M
Change in working capital 823.00M -4515.00000M 3374.00M 2194.00M 1376.00M
Stock based compensation 204.00M 212.00M 216.00M 234.00M 203.00M
Other non cash items 9523.00M -91.00000M 546.00M 1709.00M -54.00000M
Free cash flow 4321.00M -490.00000M 7254.00M 5257.00M 3295.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNC
Centene Corp		 -0.44 0.73% 59.55 - 12.85 0.11 0.94 0.09 3.79
UNH
UnitedHealth Group Incorporated		 -0.92 0.24% 377.00 22.57 18.38 1.33 5.65 1.38 13.97
CVS
CVS Health Corp		 1.87 2.09% 91.37 55.65 10.80 0.25 1.32 0.42 17.09
CI
Cigna Corp		 -1.99 0.73% 270.73 12.47 9.12 0.27 1.75 0.35
ELV
Elevance Health Inc		 2.24 0.58% 391.27 13.02 12.47 0.36 1.60 0.47

Reports Covered

Stock Research & News

View All

Profile

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corp

Centene Plaza, Saint Louis, MO, United States, 63105

Key Executives

Name Title Year Born
Ms. Sarah M. London Chief Exec. Officer & Director 1981
Mr. Brent Davis Layton Pres & COO 1968
Mr. Andrew Lynn Asher Exec. VP & CFO 1969
Mr. Christopher Andrew Koster Exec. VP, Gen. Counsel & Sec. 1965
Mr. Michael Frederic Neidorff Chairman (Leave of Absence) 1943
Ms. Katie Nicole Casso Sr. VP, Chief Accounting Office & Corp. Controller 1982
Mr. Mark J. Brooks Exec. VP & Chief Information Officer 1970
Ms. Shannon Bagley Exec. VP & Chief Admin. Officer 1979
Ms. Jennifer Lynch Gilligan Sr. VP of Investor Relations NA
Ms. Ashlee Knuckey Chief Ethics & Compliance Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions